U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07902362) titled 'Investigation of Serum Sclerostin Levels in Patients With Erectile Dysfunction' on Oct. 21.
Brief Summary: This prospective, observational case-control study aims to investigate the potential role of sclerostin-a molecule associated with cardiovascular pathologies-in the vascular pathogenesis of erectile dysfunction (ED). The study compares peripheral venous sclerostin levels between men diagnosed with ED and healthy volunteers. Additionally, it evaluates cavernosal blood sclerostin levels within the ED group to explore localized vascular changes.
Study Start Date: Jan. 02, 2023
Study Type: OBSERVATIONAL
Condition:
Erectile Dysf...